BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 16683978)

  • 21. Lamotrigine added to valproate successfully treated a case of ultra-rapid cycling bipolar disorder.
    Woo YS; Chae JH; Jun TY; Bahk WM
    Psychiatry Clin Neurosci; 2007 Feb; 61(1):130-1. PubMed ID: 17239053
    [No Abstract]   [Full Text] [Related]  

  • 22. Lamotrigine in the Prevention of Bipolar II Postpartum Depression.
    Sharma V; Sommerdyk C
    Prim Care Companion CNS Disord; 2016 Nov; 18(6):. PubMed ID: 27907274
    [No Abstract]   [Full Text] [Related]  

  • 23. The effect of lamotrigine on platelet monoamine oxidase type B activity in patients with bipolar depression.
    Muck-Seler D; Sagud M; Mustapic M; Nedic G; Babic A; Mihaljevic Peles A; Jakovljevic M; Pivac N
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Jul; 32(5):1195-8. PubMed ID: 18423830
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Successful antimanic treatment and mood stabilization with lamotrigine, clozapine, and valproate in a bipolar patient after lithium-induced cerebellar deterioration. A case report.
    Dembowski C; Rechlin T
    Pharmacopsychiatry; 2003; 36(2):83-6. PubMed ID: 12734768
    [No Abstract]   [Full Text] [Related]  

  • 25. The efficacy of lamotrigine in rapid cycling and non-rapid cycling patients with bipolar disorder.
    Hamer RM; Simpson PM
    Biol Psychiatry; 1999 Dec; 46(12):1711-2. PubMed ID: 10624556
    [No Abstract]   [Full Text] [Related]  

  • 26. Lamotrigine and the treatment of bipolar disorder. Introduction.
    Calabrese JR
    Eur Neuropsychopharmacol; 1999 Aug; 9 Suppl 4():S107-8. PubMed ID: 10524835
    [No Abstract]   [Full Text] [Related]  

  • 27. The broad clinical spectrum of bipolar disorder: implications for research and practice.
    Smith D; Ghaemi S; Craddock N
    J Psychopharmacol; 2008 Jun; 22(4):397-400. PubMed ID: 18635715
    [No Abstract]   [Full Text] [Related]  

  • 28. Recurrence in bipolar I disorder: a post hoc analysis excluding relapses in two double-blind maintenance studies.
    Calabrese JR; Goldberg JF; Ketter TA; Suppes T; Frye M; White R; DeVeaugh-Geiss A; Thompson TR
    Biol Psychiatry; 2006 Jun; 59(11):1061-4. PubMed ID: 16769295
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lack of mania prophylaxis associated with lamotrigine monotherapy in manic-predominant bipolar I disorder.
    Dossett EC; Land AJ; Gitlin MJ; Frye MA
    J Clin Psychiatry; 2007 Jun; 68(6):973-4. PubMed ID: 17592931
    [No Abstract]   [Full Text] [Related]  

  • 30. Lamotrigine: a review of clinical studies in bipolar disorders.
    Zerjav-Lacombe S; Tabarsi E
    Can J Psychiatry; 2001 May; 46(4):328-33. PubMed ID: 11387788
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Driving ability according to German guidelines in stabilized bipolar I and II outpatients receiving lithium or lamotrigine.
    Segmiller FM; Hermisson I; Riedel M; Seemüller F; Volkamer T; Laux G; Möller HJ; Brunnauer A
    J Clin Pharmacol; 2013 Apr; 53(4):459-62. PubMed ID: 23426799
    [No Abstract]   [Full Text] [Related]  

  • 32. Early-onset bipolar disorder and treatment delay are risk factors for poor outcome in adulthood.
    Post RM; Leverich GS; Kupka RW; Keck PE; McElroy SL; Altshuler LL; Frye MA; Luckenbaugh DA; Rowe M; Grunze H; Suppes T; Nolen WA
    J Clin Psychiatry; 2010 Jul; 71(7):864-72. PubMed ID: 20667291
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Overcoming the current approach in bipolar disorder research: towards DSM-V and beyond.
    Vieta E
    J Psychopharmacol; 2008 Jun; 22(4):406-7; discussion 408. PubMed ID: 18635719
    [No Abstract]   [Full Text] [Related]  

  • 34. Carbamazepine extended-release capsules use in bipolar disorder: efficacy and safety in adult patients.
    Ginsberg LD
    Ann Clin Psychiatry; 2006; 18 Suppl 1():9-14. PubMed ID: 16754406
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Early antidepressant effect of memantine during augmentation of lamotrigine inadequate response in bipolar depression: a double-blind, randomized, placebo-controlled trial.
    Anand A; Gunn AD; Barkay G; Karne HS; Nurnberger JI; Mathew SJ; Ghosh S
    Bipolar Disord; 2012 Feb; 14(1):64-70. PubMed ID: 22329473
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lamotrigine treatment of bipolar disorder: data from the first 500 patients in STEP-BD.
    Marangell LB; Martinez JM; Ketter TA; Bowden CL; Goldberg JF; Calabrese JR; Miyahara S; Miklowitz DJ; Sachs GS; Thase ME;
    Bipolar Disord; 2004 Apr; 6(2):139-43. PubMed ID: 15005752
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lamotrigine and antiepileptic drugs as mood stabilizers in bipolar disorder.
    Muzina DJ; Elhaj O; Gajwani P; Gao K; Calabrese JR
    Acta Psychiatr Scand Suppl; 2005; (426):21-8. PubMed ID: 15833097
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lamotrigine in the acute treatment of bipolar depression: results of five double-blind, placebo-controlled clinical trials.
    Calabrese JR; Huffman RF; White RL; Edwards S; Thompson TR; Ascher JA; Monaghan ET; Leadbetter RA
    Bipolar Disord; 2008 Mar; 10(2):323-33. PubMed ID: 18271912
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of mood stabilisers in the treatment of the depressive facet of bipolar disorders.
    Bourin M; Prica C
    Neurosci Biobehav Rev; 2007; 31(6):963-75. PubMed ID: 17462734
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lamotrigine for bipolar disorder: translating research into clinical practice.
    Fung J; Mok H; Yatham LN
    Expert Rev Neurother; 2004 May; 4(3):363-70. PubMed ID: 15853534
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.